Close Menu

Personalis

Personalis has launched an early-access program for its "Accuracy and Content Enhanced," or ACE, Clinical Exome test to diagnose rare Mendelian disorders, which it hopes will increase the diagnostic yield of conventional diagnostic exome sequencing.

Illumina has launched its TruGenome tests, including ones for undiagnosed disease and a predisposition screen as services through its CLIA-certified and CAP-accredited laboratory.

NEW YORK (GenomeWeb News) – Next-generation sequencing and interpretation provider Personalis has closed a $22 million Series B financing round, the company said today, bringing total investments in the firm to more than $42 million.

Personalis, provider of genetic sequencing and data interpretation to researchers and clinicians, this week formed a UK subsidiary and appointed Mark Dronsfield as the director of European sales.

Sanford-Burnham Medical Research Institute has elected Gregory Lucier to chairman of the board. He will take over from M. Wainwright Fishburn Jr., who will remain a member of the board.

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.
Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

People in the News: Adam Lowe

Premium

Personalis has hired Adam Lowe as its vice president of marketing. In this role, Lowe will recruit and lead Personalis' marketing organization and serve as a key member of its management team.

People in the News: Adam Lowe

Premium

Personalis has appointed Adam Lowe as its VP of marketing. Lowe previously served as VP of commercial operations at Oxford Nanopore Technologies.

People in the News: Adam Lowe

Premium

Personalis has appointed Adam Lowe to vice president of marketing. Lowe previously served as vice president of commercial operations at Oxford Nanopore Technologies.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.